Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Moderna ( ($MRNA) ) has risen by 10.01%. Read on to learn why. Moderna’s stock has experienced a notable increase of 10.01% over the past week, ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the ...

Moderna will offer free COVID-19 vaccines for "uninsured or underinsured people," the company announced Wednesday, pledging to ensure continued access to the shots after the public health ...

Moderna’s expected 400% hike for its COVID vaccine sparked outrage on Capitol Hill. The pharmaceutical giant could raise the price of the vaccine from its current $26 per dose to between $110 ...